Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Targeted Oncology adds Tennessee Oncology to its SAP programme
Targeted Oncology will work with Tennessee Oncology to share exclusive information in order to improve cancer care for patients. Credit: Conleth Brady / IAEA.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
SynapCon
SynapCon specialises in the development of innovative software solutions for...
About
SynapCon specialises in the development of innovative software solutions for clinical trial and medical research project management.
FollowMake an Enquiry
-
ACTide by Nubilaria
Nubilaria Srl is an Information Technology (IT) company founded in...
About
Nubilaria Srl is an Information Technology (IT) company founded in 1999. Our company has its origins in the design, management and distribution of complex database systems and innovative IT services under strict international security policies.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry